Ultrasound vendors ATL Ultrasound and Medison have formed a partnership to develop and distribute digital ultrasound systems in the $30,000 to $50,000 price range. The first step in the partnership will be the North American introduction of ATL Ultramark
Ultrasound vendors ATL Ultrasound and Medison have formed a partnership to develop and distribute digital ultrasound systems in the $30,000 to $50,000 price range. The first step in the partnership will be the North American introduction of ATL Ultramark 400, an all-digital, gray-scale scanner targeted at the ob/gyn market.
Ultramark 400 will be demonstrated this month at the American College of Obstetrics and Gynecology meeting in New Orleans. Manufacturing of Ultramark 400 will be conducted by Medison in Seoul, South Korea. Pending Food and Drug Administration 510(k) clearance, Ultramark 400 is expected to begin shipping in the third quarter, according to Bothell, WA-based ATL. The scanner will be sold in North America by ATLs womens healthcare sales force.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.